# Baxter Oncology GmbH, Halle (Westf.), Germany – FDA Inspections

Source: https://www.keypedia.com/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06

> Inspection records and compliance data for Baxter Oncology GmbH in Halle (Westf.). 12 FDA inspections on record (1 OAI), 4 Form 483s, last inspected September 26, 2025.

---

## Details

- Name: Baxter Oncology GmbH
- FEI Number: 3002806419
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Kantstr. 2
- City: Halle (Westf.)
- Country Name: Germany
- Address: Kantstr. 2, Halle (Westf.), Germany
- Country: Germany

## Related Documents

- [483 - Baxter Oncology GmbH - Unknown Date](https://www.keypedia.com/records/483/baxter-oncology-gmbh/ddb1700a-a8ff-4a53-bb34-d7a562249040) — source: FDA, date: Invalid Date
- [483 - Baxter Oncology GmbH - 2025-09-26](https://www.keypedia.com/records/483/baxter-oncology-gmbh/0d86bbfe-7f41-475c-961e-6a5a661fc1f6) — source: FDA, date: September 26, 2025
- [FDA Inspection 1283802 - Baxter Oncology GmbH - 2025-09-26](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/d2cc3497-33d6-41da-be71-fed681081e29) — classification: Official Action Indicated (OAI), source: FDA, date: September 26, 2025
- [EIR - Baxter Oncology GmbH - 2024-08-27](https://www.keypedia.com/records/eir/baxter-oncology-gmbh/926cf150-be1f-4e3c-8bcc-c1595173865d) — source: FDA, date: August 27, 2024
- [483 - Baxter Oncology GmbH - 2024-08-27](https://www.keypedia.com/records/483/baxter-oncology-gmbh/2af708b1-9a7e-4ae2-970f-cadc4ee74ce6) — source: FDA, date: August 27, 2024
- [FDA Inspection 1249702 - Baxter Oncology GmbH - 2024-08-27](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/8f606d21-cc2a-4cf4-813d-420b7e93dccc) — source: FDA, date: August 27, 2024
- [FDA Inspection 1206312 - Baxter Oncology GmbH - 2023-05-03](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/49ff9f86-3d55-44a7-abeb-1a0511f483b6) — classification: No Action Indicated (NAI), source: FDA, date: May 3, 2023
- Canada Inspection - Baxter Oncology GmbH - Inspection #82283 - 2022-11-10 — source: Canada, date: November 10, 2022
- Canada Inspection - Baxter Oncology GmbH - Inspection #75608 - 2020-01-29 — source: Canada, date: January 29, 2020
- FDA Inspection 1161093 - Baxter Oncology GmbH - 2020-01-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2020
- [483 - Baxter Oncology GmbH - 2019-11-05](https://www.keypedia.com/records/483/baxter-oncology-gmbh/f8379713-5f2d-4c65-9d44-6d8d24e6bc75) — source: FDA, date: November 5, 2019
- FDA Inspection 1106642 - Baxter Oncology GmbH - 2019-09-03 — classification: No Action Indicated (NAI), source: FDA, date: September 3, 2019
- [483 - Baxter Oncology GmbH - 2018-08-20](https://www.keypedia.com/records/483/baxter-oncology-gmbh/44a76868-527b-4e97-8b39-bf984e859eb6) — source: FDA, date: August 20, 2018
- [483 - Baxter Oncology GmbH - 2018-06-14](https://www.keypedia.com/records/483/baxter-oncology-gmbh/45f622cd-5fa3-459c-95b0-544a8450e0d7) — source: FDA, date: June 14, 2018
- [FDA Inspection 1056958 - Baxter Oncology GmbH - 2018-06-14](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/9da172d1-9118-487f-b26d-5b064e49e5f1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2018
- [FDA Inspection 1019700 - Baxter Oncology GmbH - 2017-06-27](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/64eef675-4ce9-4232-82e4-ae06945fe393) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2017
- Canada Inspection - Baxter Oncology GmbH - Inspection #70335 - 2017-01-18 — source: Canada, date: January 18, 2017
- [FDA Inspection 967376 - Baxter Oncology GmbH - 2016-03-18](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/cee1839e-90d4-436f-a2f1-187376c7dc5a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 18, 2016
- Canada Inspection - Baxter Oncology GmbH - Inspection #15504 - 2015-08-28 — source: Canada, date: August 28, 2015
- FDA Inspection 888909 - Baxter Oncology GmbH - 2014-07-01 — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2014

## Related Companies

- [Jubilant HollisterStier General Partnership](https://www.keypedia.com/companies/jubilant-hollisterstier-general-partnership/fd593d8a-dc2a-4d60-b14d-bbb95e4c0011)
- [Catalent Indiana, LLC](https://www.keypedia.com/companies/catalent-indiana-llc/3422c8c4-978a-45ba-962b-b00002fffd6d)
- [Resilience Biotechnologies, Inc.](https://www.keypedia.com/companies/resilience-biotechnologies-inc/b3d6ed53-42d5-4c02-adca-c777bb39151c)
- [Confab Laboratories Inc.](https://www.keypedia.com/companies/confab-laboratories-inc/cae88900-5d2c-47b7-aedc-3931dd4f8310)
- [EUROAPI FRANCE](https://www.keypedia.com/companies/euroapi-france/13c76923-9e4c-4b4a-becf-50fa5651afdd)
- [E-Z-EM Canada, Inc](https://www.keypedia.com/companies/e-z-em-canada-inc/de31e064-9679-4127-b65f-39ecba03c801)
- [Viva Pharmaceutical Inc](https://www.keypedia.com/companies/viva-pharmaceutical-inc/0e5d1aa3-8369-4a0d-91b7-e516415fb219)
- [Cosmetica Laboratories Inc.](https://www.keypedia.com/companies/cosmetica-laboratories-inc/bcfa9f67-ec98-41ed-a67f-62ff5060c0be)
- [Kenvue Canada Inc.](https://www.keypedia.com/companies/kenvue-canada-inc/5ebdb680-6bdf-4d05-887c-3d175e32f038)
- [Groupe Parima Inc.](https://www.keypedia.com/companies/groupe-parima-inc/49e213ea-3ec6-4535-adaf-c0b6c7d25a23)

## Related Officers

- [Vivin George](https://www.keypedia.com/people/vivin-george/0b0ee298-a577-4bee-b18e-42da0c3bb148)
- [Investigator](https://www.keypedia.com/people/karen-a-briggs/3e77d364-25ea-48c7-87f4-36f3e170bfb5)
- [other](https://www.keypedia.com/people/jeanne-m-fringer/4d970694-416e-42d6-9ec3-7bf3e337fb9a)
- [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)
- [Bingchen Du](https://www.keypedia.com/people/bingchen-du/2df8f706-844c-46b1-8461-51f0b9f0585b)
- [Sr. Pharm Quality Assessor](https://www.keypedia.com/people/sudipan-karmaker/9749496b-c89d-4581-babf-02d45d103f83)